Vertex Pharmaceuticals (NASDAQ:VRTX), a global biotechnology company with a market capitalization of $119.1 billion known for its transformative cystic fibrosis (CF) treatments, finds itself at a ...
Roper Technologies, Inc. (NASDAQ:ROP), a diversified technology company specializing in software and engineered products, has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback